e-learning
resources
Stockholm 2007
Monday 17.09.2007
Recent advances in our understanding of the mechanisms of asthma treatment
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Specific allergen immunotherapy might be safer than previous assumed when performed correct
F. Madsen, L. Frølund, M. Christensen, A. Frost, U. Søes-Petersen (Ellsinore, Hellerup, Åbemnrå, Denmark)
Source:
Annual Congress 2007 - Recent advances in our understanding of the mechanisms of asthma treatment
Session:
Recent advances in our understanding of the mechanisms of asthma treatment
Session type:
Thematic Poster Session
Number:
2157
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
F. Madsen, L. Frølund, M. Christensen, A. Frost, U. Søes-Petersen (Ellsinore, Hellerup, Åbemnrå, Denmark). Specific allergen immunotherapy might be safer than previous assumed when performed correct. Eur Respir J 2007; 30: Suppl. 51, 2157
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Management of Severe Asthma in Pediatric Patients by an Interdisciplinary Team in a Public Hospital Setting.
Respiratory sequelae of preterm birth across the life span
Related content which might interest you:
Specific immunotherapy added to pharmacologic treatment as a tool for working relocation in baker‘s occupational asthma
Source: Annual Congress 2009 - High molecular sensitisers and biological dusts
Year: 2009
Allergen specific immunotherapy efficacy in children with pollen-food allergy syndrome and different IgE profiles to recombinant component-resolved allergens.
Source: International Congress 2017 – Evolution or revolution in the treatment of asthma and allergies
Year: 2017
Capability of classical diagnostic procedure in relation with specific inhalation challenge for conclusive diagnosis in allergic asthma
Source: Annual Congress 2008 - Asthma and inhalation injuries at work
Year: 2008
Specific immunotherapy with high dose grass allergen tablets was safe in grass pollen induced asthma
Source: Eur Respir J 2005; 26: Suppl. 49, 134s
Year: 2005
Evaluation and efficacy of allergen immunotherapy in asthma
Source: Eur Respir J 2005; 26: Suppl. 49, 399s
Year: 2005
Sublinguial allergen extract immunotherapy in a rush pattern to reach the maintainance faster
Source: Annual Congress 2011 - Allergen immunotherapy and anti-immunoglobulin E
Year: 2011
Optimal dosing of specific immunotherapy (SIT) results in persisting long-term effect
Source: Eur Respir J 2001; 18: Suppl. 33, 430s
Year: 2001
Sublingual allergen specific immunotherapy in children with respiratory allergies – long lasting efficacy
Source: International Congress 2017 – Evolution or revolution in the treatment of asthma and allergies
Year: 2017
Pro: allergen avoidance is useful in preventing allergy in children
Source: Annual Congress 2009 - Lunchtime Programme “Pro/Con” Prevention of allergy by changing the infant’s diet: the emperor’s new clothes?
Year: 2009
Allergen immunotherapy: therapeutic vaccines for allergic diseases
Source: ISSN=1025-448x, ISBN=1-904097-26-x, page=409
Year: 2003
How specific and sensitive are commercial specific IgE assays in the diagnosis of occupational asthma and allergy?
Source: Annual Congress 2009 - Occupational asthma in the clinic
Year: 2009
Specific immunotherapy in grass-pollen allergic asthma combinated with inhaled steroid therapy
vs
specific immunotherapy allone
Source: Eur Respir J 2001; 18: Suppl. 33, 431s
Year: 2001
Sublingual immunotherapy is an established therapy for house dust mite sensitive allergic rhinitis and/or asthma
Source: Annual Congress 2007 - Improving asthma therapy - new findings in established and experimental treatment modalities
Year: 2007
Mimotopes for the identification of conformational epitopes of the two major mite allergens are potential candidates for epitope-specific immunotherapy
Source: Eur Respir J 2007; 30: Suppl. 51, 623s
Year: 2007
Effects of 3-yr immunotherapy with standardised extracts of house dust mite in allergic asthmatic subjects receiving appropriate drug treatment
Source: Eur Respir J 2002; 20: Suppl. 38, 107s
Year: 2002
Nasal polyps as possible target to achieve the best biological treatment choice in severe asthma
Source: International Congress 2018 – Airway disease: recent discoveries
Year: 2018
Specific immunotherapy in the management of allergic asthma
Source: Annual Congress 2008 - PG2 - Asthma: natural history, risk factors and overall management
Year: 2008
Allergen avoidance and allergic sensitisation: current views and controversies
Source: Annual Congress 2005 - MP3 - Allergen avoidance and allergic sensitisation: current views and controversies
Year: 2005
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept